axonemal motif or the closest equivalent. This is the first study to investigate the isotype-specific differences of tubulin isotypes in mammalian cilia in a functional, motility-based assay.
Materials and Methods

Preparation of cilia
Isolated bovine tracheal cilia were prepared from fresh tracheas by the method of Hastie et al. (Hastie, 1995; Hastie et al., 1986) . Tracheas from bovine lungs were obtained from a local abattoir, dissected, cleaned from debris and rinsed in cold PBS (pH 7.4). The orifices were clamped and the tracheas were then incubated with approximately 200 ml of a Triton X-100-based cilia extraction buffer under continuous shaking for 90 seconds [after Hastie, containing Tris HCl (20.0 mM), NaCl (50.0 mM), CaCl 2 (10.0 mM), EDTA (1.0 mM), 2-mercaptoethanol (7.0 mM), Triton X-100 (100.0 mM) and dithiotreitol (DTT, 1.0 mM) pH 7.4]. The fluid containing cilia was filtered through micromesh (pore size 0.45 m). After centrifugation at 10,000 g at 4°C for 7 minutes, the supernatant was discarded and the pelleted cilia were resuspended in resuspension buffer [Tris HCl (20.0 mM) , KCl (50.0 mM), MgCl 2 -6H 2 O (4.0 mM), EDTA (0.5 mM), DTT (1.0 mM), Soybean Trypsin Inhibitor (10.0 mM), pH 8.0]. The protein concentration was determined using a Bradford-dye assay. The cilia preparation was frozen in a 25% (by weight) sucrose solution in a concentration of one mg/ml in 100 l aliquots and stored at -80°C.
Activation of cilia and measuring CBF
A thawed aliquot of frozen demembranated cilia was mixed with resuspension buffer and cAMP (in resuspension buffer, final concentration 1.0 mM) in a 1:2:1 dilution (by volume). 20 l of the solution containing 0.25 mg/ml protein were then plated into wells of a 48 well culture plate (Corning Inc., Corning, NY). The plate was centrifuged at 400 g for 2 minutes at room temperature to attach the cilia to the bottom of each well. A first measurement was taken (time t=0) and 20 l of ATP in resuspension buffer (Sigma, MO) (final concentration 1.25 mM) were added to activate ciliary beating, typically at a frequency of 8-10 Hz. Test solutions containing antibodies or peptides in resuspension buffer were added at time t=3 minutes, after three readings of activated cilia. Measurements of CBF were made at intervals of 1 minute for 15-20 minutes. ATP depletion occurred at approximately 25 minutes after ATP addition. Reactivation of cilia was possible with further ATP addition, but was performed for control reasons only. For CBF measurements, antibodies and peptides were diluted in resuspension buffer.
CBF was measured using the rapid automated digital analysis system described earlier (Sisson et al., 2003) . Cilia were visualized using phase contrast microscopy (Olympus IMT-2 inverted phasecontrast microscope, Olympus America Inc., Melville, NY) directly connected to a digital camera (Kodak Megaplus ES 310 analog/digital video camera; Eastman Kodak Motion Analysis System Division, San Diego, CA) and a PC workstation (Dell Inc., Round Rock, TX). CBF was determined using Fourier analysis of the entire field of view from the digitized video.
Generation of antibodies against ␤ tubulin isotypes
Antibodies against the C-termini of ␤ tubulin isotypes were raised in mouse hybridoma cells and purified as previously described (Banerjee et al., 1990; Banerjee et al., 1992; Banerjee et al., 1988; Roach et al., 1998) . Each monoclonal antibody was prepared to an epitope unique Journal of Cell Science 118 (19) AA  432  433  434  435  436  437  438  439  440  441  442  443  444 to the C-terminus of that isotype. The C-termini of ␤ IVa and ␤ IVb are identical in amino acid sequence and therefore the antibody against ␤ IV tubulin was unable to discriminate between them. All antibodies used in this study were purified monoclonal IgG class 1 antibodies except for anti ␤ II and ␤ III tubulin, which were IgG2b (Table 2) . The antibody against the ␤ V tubulin C-terminus has not been previously reported (A.B. et al., unpublished) . The monoclonal antibody SHM 12G11 specific for mouse ␤ V tubulin was generated by immunizing mice with the C-terminal peptide EEEINE. The peptide, coupled to keyhole limpet hematocyanin (KLH), was used to immunize mice. The antibody was purified from the hybridoma supernatant using a protein-G-sepharose column. Initial immunization was performed with peptide-KLH while the subsequent immunizations were performed with peptide coupled to BSA, according to Banerjee et al. (Banerjee et al., 1988) Other antibodies were commercially obtained. The details are summarized in Table 2 . Antibodies were used at a concentration of 20 g/ml, which was within the range of concentrations used in several previous studies that employed antibodies to interfere with ciliary and flagellar beating (Bré et al., 1996; Audebert et al., 1999; Cosson et al., 1996; Gagnon et al., 1996) . Controls to assure specific antibody binding to axonemal tubulin were performed by immunohistochemistry and immunoblotting.
Visualization of antibody-labeled bovine cilia Isolated cilia were plated onto concanavalin A-coated glass microscope slides (Sigma), allowed to settle for 1 hour and fixed using a solution of 1% paraformaldehyde in PBS. No permeabilizing step was necessary since the cilia are already demembraneted. Bound antibodies were visualized using goat anti-mouse secondary antibodies conjugated to Alexa 488 (Molecular Probes, Eugene, OR). Specimens were viewed using an Axioskop II microscope (Carl Zeiss, Jena, Germany) equipped with 40ϫ and 100ϫ objectives and captured using a Spot RT digital camera (Diagnostic Instruments, Sterling Heights, MI). Images were prepared for presentation using Photoshop (Adobe Systems, San Jose, CA). Negative controls were performed by omitting the primary antibody. Positive controls for the isotype-specific ␤ tubulin antibodies were performed by staining organ of Corti tissue. The results seen were in concordance with previous observations (Hallworth and Ludueña, 2000; Vent et al., 2004 ) (see supplementary material Fig. S1 ).
Immunoblotting
Immunoblots were performed under standard conditions with all antibodies used in the above experiments. A uniform amount of homogenized axonemal proteins (15 g) was loaded onto each lane of a 10% polyacrylamide gel (Biorad, Hercules, CA). The protein content had been determined in a Bradford dye assay prior to aliquoting the extracted cilia using a microplate reader and protein (BSA) standards (MPM III 1.080, microplate reader, Biorad). The lanes were run at 100 V and 250 mA for 1 hour in sodium dodecyl sulfate electrophoresis running buffer. Proteins were then transferred from the gels to nitrocellulose sheets at 100 V and 100 mA for 1 hour in a transfer buffer containing Trizma base and glycine (Sigma). The nitrocellulose sheets containing the transferred protein lanes were then cut into strips and were exposed to one of the primary antibodies overnight at 4°C. After thorough rinsing with 1% milk in PBS, the secondary antibody (anti-mouse IgG linked to biotin, Cell Signaling Technology, Beverly, MA), was added and the strips were incubated on a rocker for 1 hour at room temperature. The protein strips were then rinsed three times in 1% milk in PBS for 10 minutes and twice in PBS for 10 minutes. They were then treated with SuperSignal West Pico Chemiluminiscent Substrate (Pierce Biotechnology, Inc., Rockford, IL) for 3 minutes and exposed to a CL-XPosure blue X-ray film (Pierce Biotechnology, Inc., Rockford, IL) for three seconds.
Generation of peptides
Axonemal motif peptides were synthesized using a previously published solid phase method (Taylor et al., 2005) . Briefly, N-␣-butyloxycarbonyl (Boc)-amino acid derivatives (Bachem Biosciences Inc., King of Prussia, PA and ChemImpex, Wood Dale, IL) were coupled to methylbenzhydrylamine resin (Bachem Biosciences Inc., King of Prussia, PA) using the coupling reagent 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate in excess base. All coupling yields were >99% as determined by the quantitative ninhydrin method (Sarin et al., 1981) . Boc groups were removed in trifluoroacetic acid (TFA, Acros Organics, Pittsburgh, PA). Peptides were cleaved from the resin using a mixture of trifluoromethanesulphonic acid/TFA/ethanedithiol/thioanisole (1/9/0.5/1, v/v) and immediately desalted on a BioGel P6 column (90ϫ2.5 cm) (Bio Gel P6, Bio Rad, Hercules, CA) in 5% aqueous acetic acid. The desalted material was loaded on to a Vydac C18 HPLC column (25ϫ2.5 cm) (Vydac C18 column, The Sep/a/ra/tions Group, Hesperia, CA) previously equilibrated with a mixture of water and acetonitrile (9/1, v/v) (Fisher Scientific, Pittsburgh, PA) containing 0.1% TFA. The concentration of acetonitrile in the eluent was increased from 10 to 40% over 50 minutes to elute the peptides from the column. Fractions containing the desired peptides were pooled and lyophilized. Peptides were judged to be >95% pure by analytical RP-HPLC and possessed satisfactory amino acid compositions.
The peptides containing the sequences EGEAEEE, EGEGEEE, EDEDEGE and GEMYEDD were custom made peptides purchased from Bachem Biosciences Inc. (King of Prussia, PA). The Cterminal tail peptides were the peptides against which the ␤ tubulin isotype specific antibodies were raised (see Table 1 and  Table 2 for sequences). Their synthesis is described elsewhere (Banerjee et al., 1990; Banerjee et al., 1992; Banerjee et al., 1988; Renthal et al., 1993) (A.B. et al., unpublished) . Unless otherwise indicated, chemicals were purchased from Sigma-Aldrich Co. (St Louis, MO).
Results
Antibodies against ␤ I , ␤ IV and ␤ V tubulin block ciliary beating We hypothesized that the C-terminus of ␤ tubulin has functional importance in ciliary beating. Thus, blocking this domain with antibodies should interfere with ciliary beating in isolated bovine cilia. On application of ATP solution (final concentration 1.25 mM) after the initial reading at time t=0, isolated cilia began to beat continuously at about 10 Hz. The CBF reached a typical steady state value by time t=3 minutes, at which time solutions containing the antibody were added at a final concentration of 20 g/ml (equivalent to 0.33 M). Axonemes maintained a steady CBF until ATP was depleted, typically after 25 minutes. Fig. 1A shows the effect of application of antibodies on CBF. Each data point is plotted as the mean and one standard error of the mean for at least six experiments. Antibodies against ␤ I, ␤ IV and ␤ V tubulin reduced CBF to zero within 8-10 minutes. By contrast, antibodies against ␤ II and ␤ III tubulin, as well as the buffer only controls (negative control), did not affect CBF. These results indicate that the isotype-specific antibodies against ␤ I , ␤ IV and ␤ V tubulin interfere with the motilitydetermining structures of microtubules, and that only those isotype-specific antibodies raised against the C-terminal sequences of ␤ I, ␤ IV and ␤ V tubulin are able to block ciliary beating.
The effect of the antibodies on CBF is concentration dependent We hypothesized that the inhibition of ciliary beating by antibodies would be specific and thus concentration dependent. To test this hypothesis, we examined the effect of antibodies at different concentrations. When the concentration of antibodies against ␤ I, ␤ IV and ␤ V tubulin was decreased in a logarithmic manner, the time taken for reduction of CBF to zero was increased. Fig. 1B shows the effect of the antibody against ␤ I tubulin on CBF at varying concentrations (20 g/ml, 2 g/ml and 0.2 g/ml final concentrations, equivalent to 0.33 M, 0.033 M and 3.3 nM, respectively). Comparable results were obtained with antibodies against ␤ I and ␤ V tubulin (data not shown). Reduction of antibody concentration by at least two orders of magnitude from the initial concentration was required to reduce the effect of the antibodies to control levels.
Preincubation of axonemes with antibodies inhibited reactivation
As a further test of the specificity of the antibody effect, we pre-incubated cilia with a molar excess (10 M) of antibody for 1 hour on ice. The high concentration was chosen to assure all epitopes would be bound by antibody. After equilibration to room temperature, ATP was added to activate ciliary beating. Normal activation to a CBF of 10 Hz was achieved in all samples except the ones containing antibodies against ␤ I, ␤ IV and ␤ V tubulin, which did not activate (see supplementary material Fig. S2 ).
Antibodies against other epitopes of ␤ tubulin, or against ␣ tubulin, have no effect on CBF We hypothesized that the effects of the antibodies against the C-termini of ␤ I, ␤ IV and ␤ V tubulin on CBF were specific to the C-terminus of tubulin isotypes. To test this hypothesis, we applied monoclonal antibodies against other epitopes of ␤ and ␣ tubulin. Fig. 1C shows the effect on CBF of an antibody against a C-terminal, non-isotype-specific epitope of ␣ tubulin (DM1A) and an antibody against a non-isotype-specific epitope (within position 281-446) of ␤ tubulin (TUB 2.1). The antibodies had no effect on CBF at the same concentration as the maximum concentration used in the above described studies. Even higher concentrations (200 g/ml or 0.66 M) did not affect CBF (data not shown). Fig. 1D shows the effect of two monoclonal non-isotype specific antibodies raised against the C-and N-termini of ␣ tubulin, respectively. They had no effect on CBF at comparable concentrations. These experiments further support the inference that the effects of the Journal of Cell Science 118 (19) antibodies against ␤ I, ␤ IV and ␤ V tubulin were specific to the binding sites of those antibodies, and that axonemal motility is dependent on the C-terminal epitope of ␤ tubulin isotypes or its direct proximity against which the antibodies are directed. Furthermore, the results indicate that there is no steric hindrance by ineffective antibodies, even against the C-terminus of ␣ tubulin, to the dynein binding site. They also exclude any non-specific inhibitory effect of the antibodies.
Specific peptides reduce CBF Nielsen et al. (Nielsen et al., 2001) hypothesized that a certain amino acid sequence, the axonemal motif, is required for ciliary function and assembly. Because of our antibody findings, we tested the axonemal motif hypothesis using synthesized heptapeptides containing the axonemal motif or amino acid sequences in corresponding positions of mammalian ␤ I, ␤ II, ␤ III, ␤ IV and ␤ V tubulin, hypothesizing that the peptides would mimic the C-terminus of ␤ tubulin and thus competitively inhibit beating. We compared their effects to the effects of the C-terminal tail peptides against which the antibodies were raised. Fig. 2A -E and Table 3 show the results of these experiments. Each plot shows the effect on CBF of the axonemal motif peptide for each isotype (open red triangles), compared to the effect of the corresponding C-terminal tail peptide (open green circles), at the same molar concentrations of peptide (final concentration 0.33 M) as was used for the antibodies. Each plot also shows the average of a series of negative control experiments (filled squares). The amino acid sequences of the C-terminal peptides are given in Tables 1 and 3. The results of these experiments are shown in Fig. 2A-E 
-, no effect; +, some inhibitory effect; ++, moderate inhibitory effect; +++, strong inhibitory effect leading to reduction of CBF to 0 Hz. in Table 3 . In general, the axonemal motif peptides were effective in reducing CBF while the C-terminal tail peptides were much less so. For example, the ␤ IV and ␤ V tubulin axonemal motif peptides completely abolished ciliary beating in 15 minutes or less, while the corresponding C-terminal tail peptides had only weak effects on CBF (Fig. 2D,E ). Both the axonemal motif and C-terminal tail peptide of ␤ III tubulin were ineffective in reducing CBF (Fig. 2C) , as expected since ␤ III tubulin is not present in the bovine cilia preparation. However, the axonemal motif peptide of ␤ II tubulin, which is also not present in bovine tracheal cilia, was effective in abolishing ciliary beating, whereas the corresponding C-terminal tail peptide had only marginal effect (Fig. 2B) . Further, both ␤ I tubulin peptides were effective in reducing CBF ( Fig. 2A) . It was observed that the content of acidic amino acids (E and D) accounts for much of the inhibitory effect on CBF. The axonemal motif-like peptides generally had five acidic amino acids (with the exception of the peptides of ␤ II tubulin and ␤ III tubulin that have four), while the C-terminal tail peptides have four acidic amino acids (with the exception of the peptides of ␤ I tubulin and ␤ III tubulin that have five and one, respectively). The C-terminal tail peptide of ␤ I tubulin (438EEAEEEA) was noted to be equally effective in reducing CBF as its axonemal motif peptide (433EEDFGEE).
The effect of the axonemal motif peptide is concentration dependent
We hypothesized that the effect of the ␤ IV tubulin axonemal motif peptide EGEFEEE is specific and therefore concentration dependent. To test this, the peptide was added to the activated cilia preparation at concentrations of 0.33 M, 0.033 M and 3.3 nM. The highest concentration of peptide reduced CBF the fastest, while the lowest concentration was essentially ineffective (Fig. 2F) .
The central phenylalanine is important in the axonemal motif sequence We observed that the axonemal motif peptides that reduced CBF contained, in addition to several acidic residues, a central F at position 436. Also, F436 is not present in the axonemal motif peptide of ␤ III tubulin, which did not reduce CBF. To test the hypothesis that F436 is important, we replaced F436 in the axonemal motif sequence (EGEFEEE) with alanine, resulting in the sequence EGEAEEE. As shown in Fig. 3A , this peptide had no effect on CBF, demonstrating the importance of F436.
Axonemal motif-like sequences in the C-terminus of ␣ tubulin are not involved in ciliary beating An E-rich sequence similar to the axonemal motif is present in the C-termini of several ␣ tubulin isotypes between positions 441 and 447, but these sequences lack the central F (Table 4) . To test the hypothesis that the C-terminus of ␣ tubulin is not involved in ciliary beating, we synthesized two peptides that represented the sequences of four ␣ tubulin isotypes: EGEGEEE (␣ II , ␣ III ) and EDEDEGE (␣ I , ␣ IV ) (Ludueña and Banerjee, 2005a; Ludueña and Banerjee, 2005b; Ludueña and Banerjee, 2005c; Ludueña and Woodward, 1975) . Neither peptide affected ciliary beating at comparable concentrations to previous experiments, supporting the antibody observations that the C-terminus of ␣ tubulin may not be directly involved in ciliary beating (Fig. 1C,D and Fig. 3B ). Antibodies are specific for axonemal tubulin We hypothesized that the effects of antibodies against ␤ I, ␤ IV and ␤ V tubulin on ciliary beating were specific for binding at the ␤ tubulin isotype specific epitopes and are not due to unspecific inhibition of beating. To test this hypothesis, all antibodies were applied to fixed preparations of bovine cilia and processed for immunofluorescence as described in the Materials and Methods. Antibodies against ␤ I, ␤ IV and ␤ V tubulin, which blocked ciliary beating, labeled cilia (Fig. 4) . The same was observed for the antibodies against the C-and N-termini of ␣ tubulin, as well as for antibodies against conserved, non-isotype-specific epitopes in the ␣ and ␤ tubulin protein (DM1A and TUB 2.1). However, they did not inhibit ciliary beating, making steric hindrance as a reason for CBF inhibition by anti ␤ I , ␤ IV and ␤ V tubulin antibodies unlikely. As expected, antibodies against ␤ tubulin isotypes not present in tracheal cilia (anti ␤ II and anti ␤ III tubulin) did not label isolated cilia in the described preparation (Fig. 4A,B) . Immunoblots of purified de-membranated cilia with all of the above mentioned primary antibodies indicated that labeling is restricted to a single band of molecular mass close to 55 kDa (Fig. 4B) , the expected molecular mass of ␤ tubulin (Ludueña, 1998) . The amino acid sequence difference between ␤ tubulin isotypes is so small that the isotypes are indistinguishable by molecular mass alone. Strong labeling appeared with anti ␤ I , DM1A and Tub 2.1 (antibodies against conserved, non-isotype specific epitopes of ␣ and ␤ tubulin) as well as the C-and Nterminus specific antibodies against ␣ tubulin. As expected, antibodies against ␤ II and ␤ III tubulin did not label the axonemal proteins at all, because ␤ II and ␤ III tubulins are not synthesized in bovine tracheal cilia. A weak band occurred at 55 kDa with labeling by antibodies against ␤ IV and ␤ V tubulin. Controls for the well-established antibodies against ␤ II and ␤ III tubulin were performed by staining the organ of Corti (supplementary material Fig. S1 ).
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Discussion
The axonemal motif is essential for ciliary function Our findings suggest that the axonemal motif, EGEFEEE, is required for ciliary function and dynein binding. Generally, the results were consistent with the number of acidic amino acids (five E or Ds) determining its effectiveness, with the exception of the axonemal motif-like peptide of ␤ II tubulin, which contains only four acidic amino acids but is equally effective as the axonemal motif. Mizuno et al. (Mizuno et al., 2004) inferred that dynein and kinesin share an overlapping binding site on the tubulin C-terminus. That paper indicated that dynein binds to either ␣ or ␤ tubulin, but not both and their results were suggestive of ␤ tubulin being the target protein. Skiniotis et al. (Skiniotis et al., 2004) further support the importance of the tubulin C-terminus by its subtilisin digestion. However, we do not exclude the possibility that other regions of tubulin are also required, analogous to the weak and strong binding states of kinesin (Skiniotis et al., 2004) . Nevertheless, findings from kinesin cannot definitively be applied to dynein. Kinesin contains a lysine (K)-rich sequence on its tubulin-binding site, termed the K-loop, which acts as a counterpart to the acidic Cterminus of tubulin (E-hook) (Okada and Hirokawa, 2000) . No such sequence exists in dynein (Asai and Koonce, 2001; Gee et al., 1997) . Inferences drawn from the interaction of kinesin with tubulin to dynein must be made carefully.
The axonemal motif sequence pivots around the central F We found that, in general, C-terminal acidic residues (E or D) are required for ciliary beating. The higher the content of acidic amino acids in the peptide, the stronger was the inhibitory effect on beating. Further, we showed that this region must pivot around the central F436 found in some ␤ tubulin isotypes. However, the study referred to earlier by Okada and Hirokawa did not evaluate dynein and did not focus on the isotypespecific differences in the C-termini of ␤ tubulins (Okada and Hirokawa, 2000) . In our study, the further requirement of a central F was established in addition to acidity as a key characteristic for axonemal function. In general, the C-terminal tail peptides, which did not contain F, were less effective than the axonemal motif peptides, with the exception of the peptides for ␤ I and ␤ V tubulin, which were equally effective. Our hypothesis is supported by the lack of effect of the two ␣ tubulin peptides (Fig. 3) which, despite being highly acidic, lack the central F.
␣ tubulin is not directly involved in ciliary beating Our evidence that ␣ tubulin is not directly involved in ciliary beating is, on first inspection, surprising. Three different antibodies against ␣ tubulin, two of which were directed against a conserved, non-isotype specific C-terminal amino acid sequence (419-435 and 426-450) , had no effect on ciliary function. Furthermore, peptides of the ␣ tubulin axonemal motif sequence did not affect CBF. Our results are consistent with recent literature that suggests no involvement of ␣ tubulin in ciliary beating (Audebert et al., 1999; Cosson et al., 1996) . Some earlier investigations favoured ␣ tubulin being important for ciliary function Hirose et al., 1999) . Goldsmith et al. (Goldsmith et al., 1991; Goldsmith et al., 1995) suggest the involvement of both ␣ and ␤ tubulin for dynein binding (Goldsmith et al., 1991; Goldsmith et al., 1995) . The role of ␣ tubulin might lie in other, yet undetermined functions. For example, ␣ tubulin may function in binding of microtubule-associated proteins (MAPs) (Rodionov et al., 1990) or interact with dynein for control of microtubule dynamics (Hunter and Wordeman, 2000) . However, those studies were conducted on cytoplasmic dynein. Hunter and Wordeman showed that the C-terminus of tubulin is necessary for MAP binding and further suggested a tubulinbinding site of dynein outside the C-terminus. Hoenger et al. describe that each kinesin dimer occupies two microtubulebinding sites (Hoenger et al., 2000) . That might be true for dynein also, but has not been investigated so far.
The periodicity of the ␣␤ tubulin heterodimer in the microtubule is 8 nm. In cytoplasmic dynein, the step size has been proposed to be dependent on cargo load and to have a minimum of 8 nm (Mallik et al., 2004) . If the step size of axonemal dynein is similar, dynein may skip ␣ tubulin and interact only with the C-terminus of ␤ tubulin.
The sequences of the peptides EDEDEGE 447 (in ␣ I and ␣ IV tubulin) and EGEGEEE 447 (in ␣ II and ␣ III tubulin) were derived from Ludueña and Banerjee (Ludueña and Banerjee, 2005a) . Due to the absence of isotype specific antibodies for ␣ tubulins, previous information on the possible distribution of ␣ tubulin isotypes was obtained by in situ hybridization. The presence of these ␣ isotypes (I-IV) in the bovine tracheal cilia preparation is plausible but not established (Ludueña and Banerjee, 2005a) , thus there is a small possibility that the peptides have no effect due to the absence of these ␣ tubulin isotypes in bovine cilia. However, antibodies against various non-isotype-specific epitopes of ␣ tubulin, including the Cterminus, also did not affect CBF.
Post-translational modifications may alter the secondary structure of the C-terminus Post-translational modifications (PTM) in tubulins occur mainly at the highly flexible C-terminus (Ludueña, 1998) . The most recently discovered PTM, polyglycylation, has been shown to occur in axonemal tubulin from Paramecium to sea urchin and mammalian spermatozoa (Bré et al., 1996) . Bré et al. also suggested an involvement of polyglycylated tubulin in axoneme motility since AXO 49 and TAP 952, monoclonal antibodies against mono-and polyglyclyated C-terminal peptides from Paramecium axonemal tubulin, specifically inhibited the reactivated motility of sea urchin spermatozoa. Polyglycylation occurs at the C-terminus and is highly variable in its amount (up to 32 glycines on a side chain off the ␥-carboxyl chain of glutamic acids E435, E437 and E438). Polyglycylation has not yet been shown to be functionally required, but may affect the secondary structure of the highly flexible C-terminus in tubulin. Gagnon et al. reported that a different PTM, polyglutamylation, in the lateral chain of ␣ tubulin plays a dynamic role in spermatozoan motility . Possibly due to steric hindrance by the large antibody, Gagnon et al. could not determine the amino acid sequence required for ciliary beating.
Isotype specificity of ␤ tubulin in axonemes This leads us back to the initial question of the existence of functional correlations of ␤ tubulin isotypes: why do some cells synthesize ␤ tubulin isotypes in one pattern and others synthesize different isotypes? Why, if the isotypes are so similar in amino acid sequence, is there still a requirement for the different isotypes? The answer may lie in the highly variable C-terminus.
It was previously found that ␤ I and ␤ IV tubulin are synthesized by all ciliated cells types tested in the gerbil . It was inferred that both isotypes are required for axonemal assembly and/ or function. However, those observations were based on immunohistochemistry alone. ␤ V tubulin was recently found to be in some but not all motile cilia (R. Hallworth and R. F. Ludueña, unpublished observations). Therefore, ␤ V tubulin may be capable of supporting ciliary beating, but may not be absolutely required for ciliary function. ␤ II tubulin has so far not been detected in cilia. However, its axonemal motif-like sequence differs only in the first amino acid from the axonemal motif sequence of ␤ IV tubulin (E433 to Q433). Further, the axonemal motif peptide of ␤ II tubulin was nearly as potent as that of ␤ IV tubulin in blocking ciliary beating. Is ␤ II tubulin incompatible with the correct axonemal assembly or function? A change in only position 433 from glutamate to glutamine is observed, resulting in a removal of one charge in ␤ II tubulin. This may indicate that the secondary structure of the synthetic peptide resembles the axonemal motif peptide more closely than does the corresponding sequence in ␤ II tubulin. It is worth noting that the unusual ␤ tubulin isotypes ␤ II and ␤ III are in some circumstances capable of supporting axonal assembly, if not motility. In the globose basal cells of the nose (the olfactory stem cells) ␤ I , ␤ II and ␤ III tubulin are synthesized and incorporated into microtubules. As soon as the cell matures and develops long, immotile sensory cilia, ␤ IV tubulin is also synthesized (Woo et al., 2002) . The isotypes do not compartmentalize, that is, all synthesized isotypes are incorporated into all microtubule structures in the cell, including the cilia. Thus ␤ II tubulin and ␤ III tubulin are at least capable of assembling into immotile cilia. It remains to been seen if ␤ II tubulin and ␤ III tubulin are capable of supporting ciliary motility and the assembly into a 9+2 structure, or if they disrupt these.
